Replimune Group, Inc. chief medical officer Konstantinos Xynos sells $349,877 of REPL shares
After the sale, the filing lists 208,017 shares held. By the Insider Stock Trader: Alerts app. Information only, not investment advice.
A chief medical officer at Replimune Group, Inc., Konstantinos Xynos, sold 16,198 shares of the company's stock on the open market on Nov 16. The sale, at an average of $21.60 a share, comes to $349,877.
The Form 4 does not tick the Rule 10b5-1 box: the sale is not reported as part of a pre-arranged trading plan. Six Replimune Group, Inc. insiders sold on the open market within 14 days, a pattern known as a cluster sell.
The trade was reported within two business days, as Section 16 requires. After the trade, the filing lists 208,017 shares held.
Figures come from the Form 4 filed with the SEC; the table lists the open-market rows this article covers.
| Company | Replimune Group, Inc. (REPL) |
|---|---|
| Insider | Konstantinos Xynos |
| Role | Chief Medical Officer |
| Transaction | Open-market sale (code S) |
| Shares | 16,198 |
| Average price | $21.60 |
| Value | $349,877 |
| Trade date | Nov 16, 2026 |
| Filed with the SEC | Nov 18, 2026, 7:32 PM ET |
| Shares held after | 208,017 |
| Ownership | Direct |
| Rule 10b5-1 plan | Not marked in the filing |
See this filing row by row in Insider Stock Trader
Follow REPL for the next insider trade · See where several insiders traded together
Source: SEC Form 4. Information only, not investment advice. Not affiliated with or endorsed by the U.S. Securities and Exchange Commission.